GSK PLC-SPON ADR (GSK) Stock Earnings & Estimates
NYSE:GSK - US37733W2044 - ADR
39.645 USD
-0.54 (-1.36%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.324B 18.74% | 30.328B 3.42% | 31.376B 3.46% | 33.153B 5.66% | 34.854B 5.13% | 36.353B 4.30% | 37.291B 2.58% | 38.13B 2.25% | 37.459B -1.76% | 36.642B -2.18% | 35.058B -4.32% | |
| EBITDA YoY % growth | 10.542B 29.73% | 10.598B 0.53% | 10.688B 0.85% | 11.254B 5.30% | 12.142B 7.89% | 12.765B 5.13% | 13.536B 6.04% | 13.607B 0.52% | 13.47B -1.01% | 12.095B -10.21% | 11.139B -7.90% | |
| EBIT YoY % growth | 8.395B 46.03% | 8.304B -1.08% | 8.137B -2.01% | 9.43B 15.89% | 10.373B 10.00% | 11.04B 6.43% | 11.981B 8.52% | 11.921B -0.50% | 11.462B -3.85% | 7.823B -31.75% | 6.619B -15.39% | |
| Operating Margin | 28.63% | 27.38% | 25.93% | 28.44% | 29.76% | 30.37% | 32.13% | 31.26% | 30.60% | 21.35% | 18.88% | |
| EPS YoY % growth | 3.02 4.54% | 3.16 4.85% | 3.25 2.77% | 3.41 4.79% | 3.67 7.84% | 4.05 10.35% | 4.37 7.90% | 4.35 -0.55% | 4.23 -2.69% | 3.26 -22.92% | 2.96 -9.37% |
All data in GBP
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.98 -3.39% | 0.53 11.19% | 0.93 1.48% | 1.02 7.93% | 1.20 22.87% | 0.61 16.90% |
| Revenue Q2Q % growth | 8.429B 5.20% | 8.469B 4.34% | 7.843B 4.35% | 8.523B 6.72% | 8.92B 5.83% | 9.1B 7.45% |
| EBITDA Q2Q % growth | 2.883B -35.72% | 1.963B -48.99% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.684B 14.41% | 1.582B 77.95% | 2.6B 12.36% | 2.802B 14.98% | 3.245B 20.90% | 1.859B 17.51% |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.95 7.14% | 0.88 | 0.07 | 7.67% |
| Q1 2025 Q2Q % growth | 0.92 4.18% | 0.83 | 0.08 | 9.85% |
| Q4 2024 Q2Q % growth | 0.47 -19.72% | 0.40 | 0.07 | 18.46% |
| Q3 2024 Q2Q % growth | 1.01 -1.39% | 0.91 | 0.10 | 10.89% |
| Q2 2024 Q2Q % growth | 0.88 11.86% | 0.80 | 0.09 | 11.14% |
| Q1 2024 Q2Q % growth | 0.88 16.49% | 0.76 | 0.11 | 14.88% |
| Q4 2023 Q2Q % growth | 0.59 12.02% | 0.60 | -0.01 | -1.98% |
| Q3 2023 Q2Q % growth | 1.03 7.46% | 0.97 | 0.05 | 5.56% |
| Q2 2023 Q2Q % growth | 0.79 12.14% | 0.74 | 0.06 | 7.52% |
| Q1 2023 Q2Q % growth | 0.75 -8.92% | 0.69 | 0.06 | 8.62% |
| Q4 2022 Q2Q % growth | 0.53 -19.37% | 0.46 | 0.06 | 13.62% |
| Q3 2022 Q2Q % growth | 0.96 2.51% | 0.84 | 0.12 | 14.45% |
| Q2 2022 Q2Q % growth | 0.71 -1.49% | 0.61 | 0.10 | 16.49% |
| Q1 2022 Q2Q % growth | 0.83 41.92% | 0.79 | 0.04 | 4.62% |
| Q4 2021 Q2Q % growth | 0.65 9.87% | 0.64 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.93 2.81% | 0.76 | 0.17 | 22.51% |
| Q2 2021 Q2Q % growth | 0.72 46.35% | 0.53 | 0.19 | 35.82% |
| Q1 2021 Q2Q % growth | 0.58 -38.77% | 0.56 | 0.02 | 3.70% |
| Q4 2020 Q2Q % growth | 0.59 -6.05% | 0.61 | -0.02 | -2.81% |
| Q3 2020 Q2Q % growth | 0.91 -7.77% | 0.80 | 0.11 | 13.09% |
| Q2 2020 Q2Q % growth | 0.49 -37.05% | 0.53 | -0.04 | -8.23% |
| Q1 2020 Q2Q % growth | 0.95 24.25% | 0.81 | 0.15 | 18.15% |
| Q4 2019 Q2Q % growth | 0.63 | 0.66 | -0.03 | -4.59% |
| Q3 2019 Q2Q % growth | 0.98 | 0.88 | 0.11 | 12.42% |
| Q2 2019 Q2Q % growth | 0.78 | 0.66 | 0.12 | 17.97% |
| Q1 2019 Q2Q % growth | 0.77 | 0.67 | 0.10 | 15.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 7.986B 1.29% | 7.989B | -3M | -0.04% |
| Q1 2025 Q2Q % growth | 7.516B 2.08% | 7.638B | -122M | -1.60% |
| Q4 2024 Q2Q % growth | 8.117B 0.81% | 7.983B | 134M | 1.68% |
| Q3 2024 Q2Q % growth | 8.012B -1.66% | 8.298B | -286M | -3.45% |
| Q2 2024 Q2Q % growth | 7.884B 9.84% | 7.695B | 189M | 2.46% |
| Q1 2024 Q2Q % growth | 7.363B 5.93% | 7.279B | 84M | 1.15% |
| Q4 2023 Q2Q % growth | 8.052B 9.16% | 7.513B | 539M | 7.17% |
| Q3 2023 Q2Q % growth | 8.147B 4.06% | 7.964B | 183M | 2.30% |
| Q2 2023 Q2Q % growth | 7.178B 3.59% | 7.032B | 146M | 2.08% |
| Q1 2023 Q2Q % growth | 6.951B -3.32% | 6.634B | 317M | 4.78% |
| Q4 2022 Q2Q % growth | 7.376B 4.24% | 7.563B | -187M | -2.47% |
| Q3 2022 Q2Q % growth | 7.829B 18.14% | 7.555B | 274M | 3.63% |
| Q2 2022 Q2Q % growth | 6.929B 18.69% | 6.702B | 227M | 3.39% |
| Q1 2022 Q2Q % growth | 7.19B -3.07% | 9.265B | -2.075B | -22.40% |
| Q4 2021 Q2Q % growth | 7.076B -19.03% | 9.782B | -2.706B | -27.66% |
| Q3 2021 Q2Q % growth | 6.627B -23.35% | 8.986B | -2.359B | -26.25% |
| Q2 2021 Q2Q % growth | 5.838B -23.43% | 7.785B | -1.947B | -25.01% |
| Q1 2021 Q2Q % growth | 7.418B -18.39% | 8.12B | -702M | -8.65% |
| Q4 2020 Q2Q % growth | 8.739B -1.80% | 9.001B | -262M | -2.91% |
| Q3 2020 Q2Q % growth | 8.646B -7.87% | 9.034B | -388M | -4.29% |
| Q2 2020 Q2Q % growth | 7.624B -2.37% | 7.953B | -329M | -4.14% |
| Q1 2020 Q2Q % growth | 9.09B 18.65% | 8.949B | 141M | 1.58% |
| Q4 2019 Q2Q % growth | 8.899B | 9.29B | -391M | -4.21% |
| Q3 2019 Q2Q % growth | 9.385B | 9.326B | 59M | 0.63% |
| Q2 2019 Q2Q % growth | 7.809B | 7.805B | 4M | 0.05% |
| Q1 2019 Q2Q % growth | 7.661B | 7.776B | -115M | -1.48% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4.01% | -5.07% | -3.92% | -3.48% |
| Revenue | 0.72% | -1.68% | -0.97% | -0.97% |